It is widely accepted and recognized that psychodermatologic issues are commonly encountered in dermatological practices.
By Kate Buron A recent study published in the Journal of the American Academy of Dermatology (JAAD) found that children with atopic dermatitis (AD) are more likely than their peers without AD to experience symptoms of anxiety, depression, attention deficit-hyperactivity disorder (ADHD) and other behavior and psychosocial issues. Although the mechanistic link between AD and […]
Although it is most commonly used for aesthetic purposes, the medical applications of botulinum toxin (Botox) range further than merely cosmetic indications. Research has found that botulinum toxin injections have been reported to reduce migraine symptoms in patients with chronic migraine. In addition, burgeoning evidence implicates the potential role of Botox injections in the treatment […]
Atopic dermatitis (AD), or eczema, is a cause of suffering for many U.S. adults, impacting not only their skin health but also productivity levels, mental health, and quality of life. Current data reveals the high prevalence and disease burden of atopic eczema, with an estimate of 16.5 million adult cases and 6.6 million of those […]
Advances in the field of aesthetic medicine continue to introduce new and improved treatment modalities, offering physicians and patients a wide array of therapeutic options to choose from. While the visible symptoms of skin concerns can now more than ever be easily mitigated, researchers are increasingly beginning to focus on the less tangible factors contributing […]
An article in Metro begins with the sentence, “When we’re living in a society obsessed with Instagram, it’s no surprise most of us crave flawless skin.” Yet for those diagnosed with chronic skin conditions, the ideal is not only unattainable—it can also be detrimental to emotional wellbeing and mental health. In an effort to establish a […]